Data / Form D filings / PLASMATECH BIOPHARMACEUTICALS INC
PLASMATECH BIOPHARMACEUTICALS INC: Form D filings
PLASMATECH BIOPHARMACEUTICALS INC, a pharmaceuticals company in Dallas, TX, filed 4 Form D notices with the SEC between 2011 and 2015. The latest, on June 1, 2015, reports $13.7 million sold of a $22.7 million offering to 17 investors.
Find out what PLASMATECH BIOPHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4848 Lemmon Avenue, Suite 517, Dallas, TX, 75219
- Phone
- (214) 905-5100
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 318306
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 1, 2015 | New notice | $22,664,509 | $13,664,509 | $9,000,000 | 17 | May 15, 2015 | sec.gov |
| May 22, 2015 | New notice | $10,000,000 | $10,000,000 | $0 | 2 | May 11, 2015 | sec.gov |
| Nov 2, 2012 | New notice | $10,000,000 | $10,000,000 | $0 | 1 | Oct 25, 2012 | sec.gov |
| Nov 14, 2011 | New notice | $5,581,502 | $5,581,502 | $0 | 14 | Nov 10, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stephen B. Howell | Director | |
| Jeffrey H. Davis | Director | |
| Tim B. Miller | Executive Officer, Director | |
| Steven H. Rouhandeh | Executive Officer | |
| Stephen B. Thompson | Executive Officer | |
| Todd B. Wider | Director | |
| Mark J. Ahn | Director | |
| Mark J. Alvino | Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
Every Form D from the week of Jun 1, 2015 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what PLASMATECH BIOPHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.